Home » Pharmaceutical Contract Sales Outsourcing (CSO) Market

Pharmaceutical Contract Sales Outsourcing (CSO) Market By Service (Personal promotion, Non-personal Promotion, Others) By Therapeutic area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, Others)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 19735 | Report Format : PDF

Key Highlights of the Report

The global pharmaceutical contract sales outsourcing (CSO) market are segmented by service, therapeutic area, and region. The personal promotion segment is the most popular service segment. Cardiovascular disorders is the top leading therapeutic area segment, with North America leading the market growth.

The global pharmaceutical contract sales outsourcing (CSO) market have been driven by several factors, such as the as pharmaceutical companies are increasingly looking to streamline their operations and reduce costs, making (CSO) an attractive option for sales functions & expanded the reach of pharmaceutical companies due to globalization. However, the market also faces significant challenges, including concerns regarding data security and confidentiality when outsourcing sales functions, particularly due to the sensitive nature of pharmaceutical industry information.

Nonetheless, the global pharmaceutical contract sales outsourcing (CSO) market offers significant growth opportunities, such as CSO offering pharmaceutical companies access to a highly trained and specialized sales force without the need for extensive recruitment and training efforts.

Market Overview

The global pharmaceutical contract sales outsourcing (CSO) market has witnessed steady growth in recent years and is expected to grow at a CAGR of 7.30% between 2023 and 2030. The market was valued at USD 9.3 billion in 2022 and is expected to reach USD 15.22933719 billion in 2030.

What Are the Main Drivers Of The Global Pharmaceutical contract sales outsourcing (CSO) Market?

The global pharmaceutical contract sales outsourcing (CSO) market is driven by several factors, such as pharmaceutical companies are increasingly looking to streamline their operations and reduce costs, making (CSO) an attractive option for sales functions & expanded the reach of pharmaceutical companies due to globalization.

What Are the Major Challenges Faced by The Global pharmaceutical contract sales outsourcing (CSO) Market?

The global pharmaceutical contract sales outsourcing (CSO) market also face several challenges, such as concerns regarding data security and confidentiality when outsourcing sales functions, particularly due to the sensitive nature of pharmaceutical industry information.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

What Are the Growth Opportunities in The Global Pharmaceutical contract sales outsourcing (CSO) market?

The global pharmaceutical contract sales outsourcing (CSO) market offers significant growth opportunities, such as CSO offering pharmaceutical companies access to a highly trained and specialized sales force without the need for extensive recruitment and training efforts.

Executive Summary

Overview of the Global pharmaceutical contract sales outsourcing (CSO) market

The global pharmaceutical contract sales outsourcing (CSO) market has been steadily growing in recent years due to the expanding nature of pharmaceutical companies due to globalization, and pharmaceutical companies are increasingly looking to streamline their operations and reduce costs, making (CSO) an attractive option for sales functions.

Market Definition

The global pharmaceutical contract sales outsourcing ((CSO)) market refers to the practice of pharmaceutical companies partnering with external service providers to outsource their sales and marketing functions. In this arrangement, the CSO are responsible for promoting and selling the pharmaceutical company’s products to healthcare professionals. It may provide a range of services, including sales representatives, field forces, telesales, market research, and analytics. The goal of pharmaceutical CSO is to enhance sales effectiveness, expand market reach, and improve operational efficiency for the pharmaceutical companies. Pharmaceutical firms may concentrate on their core capabilities while utilising the external sales experience that CSO frequently bring with them in the form of specialised knowledge, resources, and flexibility.

Market Insights

  • The global demand for pharmaceutical contract sales outsourcing (CSO) was valued at USD 9.3 Billion in 2022 and is expected to reach USD 15.22933719 Billion in 2030, growing at a CAGR of 7.30% between 2023 and 2030.
  • Personal promotion service is the leading segment and held more than four-fifth of the share in terms of value in 2022.
  • Cardiovascular Disorders is expected to post the highest CAGR during the forecast period & leading the market share with more than 35% share in 2022, while the metabolic disorders therapeutic area segment is likely to exhibit the fastest CAGR during the forecast period.
  • North America is fueling the growth of the pharmaceutical contract sales outsourcing (CSO) industry with a nearly three-firth share in 2022, while Europe and Asia-pacific collectively accounted for just nearly under 65% share in 2022. Europe held more than 40% share in 2022.
  • The major driver that drives the market is that pharmaceutical companies are increasingly looking to streamline their operations and & expand the reach of pharmaceutical companies due to globalization.
  • At the same time, increasing scrutiny and regulations within the healthcare industry that can impact the operations and compliance of CSO are the main restraints.
  • It offers pharmaceutical companies access to a highly trained and specialized sales force without the need for extensive recruitment and training efforts are some of the major opportunities in the market.

Segmentation by Therapeutic area

  • The Cardiovascular Disorders Service is the leading segment and held more than 35% share in value in 2022.
  • The metabolic disorders therapeutic area segment is likely to exhibit the fastest CAGR during the forecast period.

Segmentation by Service

  • The personal promotion service segment governs the demand for the pharmaceutical contract sales outsourcing (CSO) industry globally, holding a four-fifth share, and is also expected to grow at a rapid CAGR.
  • Non-personal Promotion Service held massive CAGR for pharmaceutical contract sales outsourcing (CSO) market.

Segmentation by Region

  • North America was fueling the growth of the pharmaceutical contract sales outsourcing (CSO) industry with a nearly two-third share in 2022.
  • Europe and Asia-pacific collectively account for nearly under 65% share in 2022, with Europe held more than 40% share in 2022.
  • The rest of the world, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for pharmaceutical contract sales outsourcing (CSO).

As pharmaceutical companies are increasingly looking to streamline their operations and reduce costs, making (CSO) an attractive option for sales functions also expanded the reach of pharmaceutical companies due to globalization driving the market.

The US pharmaceutical companies are increasingly seeking cost-effective solutions to streamline their operations. By outsourcing sales functions to CSO, they can reduce overhead costs associated with recruiting, training, and managing an in-house sales force. The healthcare landscape in the US is evolving rapidly, with complex regulations and market dynamics. CSO offer specialized expertise and knowledge in navigating these challenges, ensuring compliance, and maximizing sales potential. Additionally, advancements in technology and data analytics have enhanced the capabilities of CSO. They can leverage data-driven insights to identify key market trends, target healthcare professionals more effectively, and track sales performance.

Japan has a rapidly aging population, resulting in an increased demand for healthcare services and pharmaceutical products. This has led pharmaceutical companies to expand their market presence and sales efforts, creating opportunities for CSO to support their sales and marketing activities. The Japanese healthcare landscape is characterized by a high level of fragmentation, with various regional and specialty-focused healthcare providers. CSO can provide local market knowledge, establish relationships with key healthcare professionals, and customize sales strategies to target specific regions or therapeutic areas.

Increasingly seeking cost-effective solutions

Pharmaceutical companies are increasingly seeking cost-effective solutions to optimize their operations. Outsourcing sales functions to CSO can result in significant cost savings. For example, a pharmaceutical company may have a seasonal product that requires a dedicated sales force only during specific months of the year. Instead of maintaining a full-time in-house sales team, the company can partner with a (CSO) to provide a flexible sales force that can be scaled up or down as needed. This allows the company to reduce fixed costs associated with salaries, benefits, and infrastructure, ultimately improving their cost efficiency.

Specialized Expertise and market knowledge

The healthcare industry, including the pharmaceutical sector, is becoming increasingly complex and specialized. CSO offer specialized expertise and market knowledge, enabling pharmaceutical companies to benefit from their experience and insights. For instance, a pharmaceutical company developing a new rare disease drug may lack in-house expertise in that specific therapeutic area. By partnering with a (CSO) that specializes in rare diseases, the company can leverage their deep understanding of the target patient population, treatment landscape, and physician network. The (CSO) can provide tailored sales strategies, key opinion leader (KOL) engagement, and insights into market dynamics, maximizing the product’s potential in a niche market.

Potential Risk to Reputation and Loss of Customer Relationships

Pharmaceutical companies often build strong relationships with healthcare professionals, such as physicians, pharmacists, and hospitals. These relationships are built on trust and long-term collaboration. When sales functions are outsourced to a (CSO), there is a risk that the (CSO)’s actions or performance may not align with the company’s values or quality standards, leading to a negative impact on the company’s reputation. To mitigate this risk, pharmaceutical companies must carefully select reputable and trustworthy CSO that align with their values and quality standards. Robust contracts and clear expectations should be established to ensure compliance with regulations, ethical guidelines, and the company’s sales strategies. Regular monitoring, training, and performance evaluations of the (CSO)’s sales representatives are also essential to maintain alignment with the company’s standards and protect its reputation.

Access To a Highly Trained and Specialized Sales Force

Pharmaceutical companies require skilled sales professionals who possess deep knowledge of the industry, products, and healthcare landscape. However, recruiting, training, and managing an in-house sales team can be time-consuming and resource-intensive. For instance, a pharmaceutical company launching a new product in a specific therapeutic area may lack the necessary in-house expertise to effectively penetrate the market. By partnering with a (CSO) specialized in that therapeutic area, the company gains immediate access to a sales team with in-depth knowledge and established relationships with key healthcare professionals.

Competitive Landscape

Key Players

The global pharmaceutical contract sales outsourcing (CSO) market is highly competitive, with the presence of several key players. Some of the major players in the market and their market share are as follows:

  • IQVIA Inc.
  • Syneos Health Inc.
  • Parexel International Corporation
  • Pharmaceutical Product Development (PPD) LLC
  • inVentiv Health Inc. (part of Syneos Health)
  • ICON plc
  • Publicis Touchpoint Solutions, Inc.
  • PRA Health Sciences, Inc.
  • The Medical Affairs Company (TMAC)
  • Ashfield Healthcare Communications Group (part of UDG Healthcare plc)

These companies focus on service innovation, expanding their Service, mergers, and acquisitions to stay ahead in the market.

The major players in the global pharmaceutical contract sales outsourcing (CSO) market constantly strive to stay ahead by introducing new technologies and innovations.

IQVIA, Inc., entered into partnership with Dr. Reddy’s Laboratories. As per the partnership, IQVIA provided Dr. Reddy with its Orchestrated Customer Engagement (OCE) platform to support its CRM operations.

Summary of Key Findings

  • As pharmaceutical companies are increasingly looking to streamline their operations and reduce costs, making (CSO) an attractive option for sales functions driving market growth
  • Market segmented by service, therapeutic area, and region.
  • Personal promotion is the most popular service segment, with Metabolic disorders therapeutic area as the primary Service segment.
  • Cardiovascular Disorders is the most common therapeutic area segment.
  • North America is leading market growth; the market is highly competitive with key players including IQVIA Inc., Syneos Health Inc., Parexel International Corporation, Pharmaceutical Product Development (PPD) LLC, inVentiv Health Inc. (part of Syneos Health), ICON plc and others.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Future Outlook

  • Positive outlook for the global pharmaceutical contract sales outsourcing (CSO) market with significant growth potential in the North America region
  • Advancements in technology and expanded the reach of pharmaceutical companies due to globalization driving the growth of the market.
  • Challenges like concerns regarding data security and confidentiality when outsourcing sales functions, particularly due to the sensitive nature of pharmaceutical industry information.

Segmentation

  • By Service
    • Personal promotion
    • Non-personal Promotion
    • Others
  • By Therapeutic area
    • Cardiovascular Disorders
    • Oncology
    • Metabolic Disorders
    • Neurology
    • Orthopedic Diseases
    • Infectious Diseases
    • Others
  • By Region
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Pharmaceutical contract sales outsourcing (CSO) Market
2.2. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Service
2.3. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Therapeutic Area
2.4. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Pharmaceutical contract sales outsourcing (CSO) Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Service
3.5.2. Therapeutic Area
3.5.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnership
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Service
7.1. Global Pharmaceutical contract sales outsourcing (CSO) Market Overview, by Service
7.1.1. Global Pharmaceutical contract sales outsourcing (CSO) Market Revenue Share, By Service, 2022 Vs 2030 (in %)
7.2. Personal Promotion
7.2.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region, 2017-2030 (US$ Bn)
7.3. Non-personal Promotion
7.3.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region, 2017-2030 (US$ Bn)
7.4. Others
7.4.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region, 2017-2030 (US$ Bn)

8. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Therapeutic Area
8.1. Global Pharmaceutical contract sales outsourcing (CSO) Market Overview, by Therapeutic Area
8.1.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Therapeutic Area, 2022 vs 2030 (in %)
8.2. Cardiovascular Disorders
8.2.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region, 2017-2030 (US$ Bn)
8.3. Oncology
8.3.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region, 2017-2030 (US$ Bn)
8.4. Metabolic Disorders
8.4.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region, 2017-2030 (US$ Bn)
8.5. Neurology
8.5.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region, 2017-2030 (US$ Bn)
8.6. Orthopedic Diseases
8.6.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region, 2017-2030 (US$ Bn)
8.7. Infectious Diseases
8.7.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region, 2017-2030 (US$ Bn)
8.8. Other
8.8.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region, 2017-2030 (US$ Bn)

9. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region
9.1. Global Pharmaceutical contract sales outsourcing (CSO) Market Overview, by Region
9.1.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Region, 2022 vs 2030 (in%)
9.2. Service
9.2.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Service, 2017-2030 (US$ Bn)
9.3. Therapeutic Area
9.3.1. Global Pharmaceutical contract sales outsourcing (CSO) Market, By Therapeutic Area, 2017-2030 (US$ Bn)

10. North America Pharmaceutical contract sales outsourcing (CSO) Market Analysis
10.1. North America Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. North America Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. North America Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2017-2030 (US$ Bn)
10.3.1. North America Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2022 Vs 2030 (in%)
10.3.2. U.S.
10.3.2.1. U.S. Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.2.2. U.S. Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
10.3.2.3. U.S. Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
10.3.3. Canada
10.3.3.1. Canada Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.3.2. Canada Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
10.3.3.3. Canada Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
10.3.4. Mexico
10.3.4.1. Mexico Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.3.4.2. Mexico Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
10.3.4.3. Mexico Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)

11. Europe Pharmaceutical contract sales outsourcing (CSO) Market Analysis
11.1. Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2017-2030 (US$ Bn)
11.3.1. Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2022 Vs 2030 (in%)
11.3.2. Germany
11.3.2.1. Germany Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.2.2. Germany Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
11.3.2.3. Germany Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
11.3.3. France
11.3.3.1. France Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.3.2. France Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
11.3.3.3. France Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
11.3.4. UK
11.3.4.1. UK Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.4.2. UK Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
11.3.4.3. UK Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
11.3.5. Italy
11.3.5.1. Italy Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.5.2. Italy Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
11.3.5.3. Italy Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
11.3.6. Spain
11.3.6.1. Spain Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.6.2. Spain Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
11.3.6.3. Spain Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
11.3.7. Rest of Europe
11.3.7.1. Rest of Europe Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.3.7.2. Rest of Europe Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
11.3.7.3. Rest of Europe Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)

12. Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market Analysis
12.1. Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2017-2030 (US$ Bn)
12.3.1. Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2022 Vs 2030 (in%)
12.3.2. China
12.3.2.1. China Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.2.2. China Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
12.3.2.3. China Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
12.3.3. Japan
12.3.3.1. Japan Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.3.2. Japan Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
12.3.3.3. Japan Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
12.3.4. India
12.3.4.1. India Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.4.2. India Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
12.3.4.3. India Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
12.3.5. South Korea
12.3.5.1. South Korea Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.5.2. South Korea Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
12.3.5.3. South Korea Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
12.3.6. South-East Asia
12.3.6.1. South-East Asia Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.6.2. South-East Asia Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
12.3.6.3. South-East Asia Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
12.3.7. Rest of Asia Pacific
12.3.7.1. Rest of Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.3.7.2. Rest of Asia Pacific Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
12.3.7.3. Rest of Asia Pacific Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)

13. Latin America Pharmaceutical contract sales outsourcing (CSO) Market Analysis
13.1. Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2017-2030 (US$ Bn)
13.3.1. Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2022 Vs 2030 (in%)
13.3.2. Brazil
13.3.2.1. Brazil Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.2.2. Brazil Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
13.3.2.3. Brazil Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
13.3.3. Argentina
13.3.3.1. Argentina Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.3.2. Argentina Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
13.3.3.3. Argentina Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
13.3.4. Rest of Latin America
13.3.4.1. Rest of Latin America Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.3.4.2. Rest of Latin America Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
13.3.4.3. Rest of Latin America Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)

14. Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market Analysis
14.1. Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2017-2030 (US$ Bn)
14.3.1. Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2022 Vs 2030 (in%)
14.3.2. GCC Countries
14.3.2.1. GCC Countries Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.2.2. GCC Countries Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
14.3.2.3. GCC Countries Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
14.3.3. South Africa
14.3.3.1. South Africa Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.3.2. South Africa Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
14.3.3.3. South Africa Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)
14.3.4. Rest of Middle East and Africa
14.3.4.1. Rest of Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.3.4.2. Rest of Middle East and Africa Pharmaceutical contract sales outsourcing (CSO), By Service, 2017-2030 (US$ Bn)
14.3.4.3. Rest of Middle East and Africa Pharmaceutical contract sales outsourcing (CSO), By Therapeutic Area, 2017-2030 (US$ Bn)

15. Company Profiles
15.1. IQVIA Inc.
15.1.1. Company Overview
15.1.2. Product /Services Portfolio
15.1.3. Geographical Presence
15.1.4. Financial Summary
15.1.4.1. Market Revenue and Net Profit (2019-2022)
15.1.4.2. Business Segment Revenue Analysis
15.1.4.3. Geographical Revenue Analysis
15.2. Syneos Health Inc.
15.3. Parexel International Corporation
15.4. Pharmaceutical Product Development (PPD) LLC
15.5. inVentiv Health Inc. (part of Syneos Health)
15.6. ICON plc
15.7. Publicis Touchpoint Solutions, Inc.
15.8. PRA Health Sciences, Inc.
15.9. The Medical Affairs Company (TMAC)
15.10. Ashfield Healthcare Communications Group (part of UDG Healthcare plc)

List of Figures
FIG. 1 Global Pharmaceutical contract sales outsourcing (CSO) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Pharmaceutical contract sales outsourcing (CSO) Market Segmentation
FIG. 4 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2022 (US$ Bn)
FIG. 5 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2022 (US$ Bn)
FIG. 6 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Geography, 2022 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Service, 2022
FIG. 8 Attractive Investment Proposition, by Therapeutic Area, 2022
FIG. 9 Attractive Investment Proposition, by Geography, 2022
FIG. 10 Global Market Share Analysis of Key Pharmaceutical contract sales outsourcing (CSO) Market Manufacturers, 2022
FIG. 11 Global Market Positioning of Key Pharmaceutical contract sales outsourcing (CSO) Market Manufacturers, 2022
FIG. 12 Global Pharmaceutical contract sales outsourcing (CSO) Market Value Contribution, By Service, 2022 & 2030 (Value %)
FIG. 13 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Personal Promotion, Value, 2017-2030 (US$ Bn)
FIG. 14 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Non-personal Promotion, Value, 2017-2030 (US$ Bn)
FIG. 15 Global Pharmaceutical contract sales outsourcing (CSO) Market, by others, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Pharmaceutical contract sales outsourcing (CSO) Market Value Contribution, By Therapeutic Area, 2022 & 2030 (Value %)
FIG. 17 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Cardiovascular Disorders, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Oncology, 2017-2030 (US$ Bn)
FIG. 19 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Metabolic Disorders, 2017-2030 (US$ Bn)
FIG. 20 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Neurologyl, 2017-2030 (US$ Bn)
FIG. 21 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Orthopedic Diseases, 2017-2030 (US$ Bn)
FIG. 22 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Infectious Diseases, 2017-2030 (US$ Bn)
FIG. 23 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Other, 2017-2030 (US$ Bn)
FIG. 24 North America Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 25 U.S. Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 26 Canada Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 27 Europe Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 28 Germany Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 29 France Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 30 U.K. Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 31 Italy Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 32 Spain Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 33 Rest of Europe Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 34 Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 35 China Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 36 Japan Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 37 India Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 38 South Korea Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 39 South-East Asia Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 40 Rest of Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 41 Latin America Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 42 Brazil Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 43 Mexico Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 44 Rest of Latin America Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 45 Middle East & Africa Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 46 GCC Countries Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 47 South Africa Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)
FIG. 48 Rest of Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Pharmaceutical contract sales outsourcing (CSO) Market
TABLE 2 Global Pharmaceutical contract sales outsourcing (CSO) Market: Market Drivers Impact Analysis
TABLE 3 Global Pharmaceutical contract sales outsourcing (CSO) Market: Market Restraints Impact Analysis
TABLE 4 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Competitive Benchmarking, 2022
TABLE 5 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Key Strategies Analysis, 2022
TABLE 7 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Personal Promotion, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Personal Promotion, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Non-personal Promotion, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Non-personal Promotion, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Pharmaceutical contract sales outsourcing (CSO) Market, by others, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Pharmaceutical contract sales outsourcing (CSO) Market, by others, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Cardiovascular Disorders, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Cardiovascular Disorders, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Oncology, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Oncology, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Metabolic Disorders, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Metabolic Disorders, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Neurology, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Neurology, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Orthopedic Diseases, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Orthopedic Diseases, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Infectious Diseases, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Infectious Diseases, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Other, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Other, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 28 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 29 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 30 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 31 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Region, 2017-2022 (US$ Bn)
TABLE 32 Global Pharmaceutical contract sales outsourcing (CSO) Market, by Region, 2023-2030 (US$ Bn)
TABLE 33 North America Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 34 North America Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 35 North America Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 36 North America Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 37 North America Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2017-2022 (US$ Bn)
TABLE 38 North America Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2023-2030 (US$ Bn)
TABLE 39 United States Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 40 United States Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 41 United States Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 42 United States Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 43 Canada Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 44 Canada Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 45 Canada Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 46 Canada Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 47 Mexico Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 48 Mexico Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 49 Mexico Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 50 Mexico Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 51 Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 52 Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 53 Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 54 Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 55 Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2017-2022 (US$ Bn)
TABLE 56 Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2023-2030 (US$ Bn)
TABLE 57 Germany Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 58 Germany Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 59 Germany Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 60 Germany Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 61 France Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 62 France Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 63 France Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 64 France Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 65 United Kingdom Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 66 United Kingdom Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 67 United Kingdom Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 68 United Kingdom Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 69 Italy Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 70 Italy Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 71 Italy Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 72 Italy Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 73 Spain Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 74 Spain Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 75 Spain Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 76 Spain Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 77 Rest of Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 78 Rest of Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 79 Rest of Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 80 Rest of Europe Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 81 Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 82 Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 83 Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 84 Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 85 Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2017-2022 (US$ Bn)
TABLE 86 Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2023-2030 (US$ Bn)
TABLE 87 China Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 88 China Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 89 China Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 90 China Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 91 Japan Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 92 Japan Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 93 Japan Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 94 Japan Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 95 India Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 96 India Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 97 India Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 98 India Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 99 South Korea Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 100 South Korea Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 101 South Korea Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 102 South Korea Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 103 South-East Asia Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 104 South-East Asia Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 105 South-East Asia Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 106 South-East Asia Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 107 Rest of Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 108 Rest of Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 109 Rest of Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 110 Rest of Asia Pacific Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 111 Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 112 Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 113 Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 114 Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 115 Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2017-2022 (US$ Bn)
TABLE 116 Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2023-2030 (US$ Bn)
TABLE 117 Brazil Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 118 Brazil Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 119 Brazil Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 120 Brazil Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 121 Argentina Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 122 Argentina Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 123 Argentina Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 124 Argentina Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 125 Rest of Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 126 Rest of Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 127 Rest of Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 128 Rest of Latin America Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 129 Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 130 Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 131 Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 132 Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 133 Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2017-2022 (US$ Bn)
TABLE 134 Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Country, 2023-2030 (US$ Bn)
TABLE 135 GCC Countries Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 136 GCC Countries Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 137 GCC Countries Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 138 GCC Countries Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 139 South Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 140 South Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 141 South Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 142 South Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)
TABLE 143 Rest of Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2017-2022 (US$ Bn)
TABLE 144 Rest of Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Service, 2023-2030 (US$ Bn)
TABLE 145 Rest of Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2017-2022 (US$ Bn)
TABLE 146 Rest of Middle East and Africa Pharmaceutical contract sales outsourcing (CSO) Market, by Therapeutic Area, 2023-2030 (US$ Bn)

Frequently Asked Questions:

What is the current size of the global pharmaceutical contract sales outsourcing (CSO) market?

The global pharmaceutical contract sales outsourcing (CSO) market was valued at USD 9.3 Billion in 2022.

What is the expected growth rate of the pharmaceutical contract sales outsourcing (CSO) market between 2023 and 2030?

The Pharmaceutical contract sales outsourcing (CSO) market is expected to grow at a CAGR of 7.30% between 2023 and 2030, reaching USD 15.22933719 Billion in 2030.

Which segment is leading the market share in terms of service?

Personal promotion service vaccine is the leading segment by service, holding around more than four-fifth of the share in value in 2022.

Which therapeutic area governs the demand for pharmaceutical contract sales outsourcing (CSO) market in the world?

Cardiovascular Disorders governs the demand for pharmaceutical contract sales outsourcing (CSO) globally, holding a massive share of nearly 35% in 2022.

Which segment is expected to post the highest CAGR during the forecast period?

Metabolic disorders therapeutic area segment is expected to post the highest CAGR during the forecast period.

Which region is fueling the growth of the pharmaceutical contract sales outsourcing (CSO) industry?

North America is fueling the growth of the pharmaceutical contract sales outsourcing (CSO) industry, with nearly a three-firth share in 2022.

Who are the major players in the global pharmaceutical contract sales outsourcing (CSO) market?

The top players include IQVIA Inc., Syneos Health Inc., Parexel International Corporation, Pharmaceutical Product Development (PPD) LLC, inVentiv Health Inc. (part of Syneos Health), ICON plc and others.

What is the major market driver of the pharmaceutical contract sales outsourcing (CSO) industry?

As pharmaceutical companies are increasingly looking to streamline their operations and reduce costs, making (CSO) an attractive option for sales functions & expanded the reach of pharmaceutical companies due to globalization are some of the market drivers.

What are the major market restraints of the pharmaceutical contract sales outsourcing (CSO) industry?

Rising scrutiny and regulations within the healthcare industry that can impact the operations and compliance of CSO & availability of skilled and experienced sales professionals for outsourcing purposes still restraints on the pharmaceutical contract sales outsourcing (CSO) industry.

What are the major market opportunities of the pharmaceutical contract sales outsourcing (CSO) industry?

CSO offer pharmaceutical companies access to a highly trained and specialized sales force without the need for extensive recruitment and training efforts & they can assist in navigating complex regulatory environments, ensuring compliance, and minimizing risks are some of the opportunities of the market.

Quality Management Software Market

Published:
Report ID: 8459

Multichannel Order Management Market

Published:
Report ID: 24142

Architecture Engineering and Construction (AEC) Software Market

Published:
Report ID: 19572

Loan-Servicing Software Market

Published:
Report ID: 19516

Blockchain in BFSI Market

Published:
Report ID: 19053

Enterprise Agile Transformation Services Market

Published:
Report ID: 19031

Fintech Software Market

Published:
Report ID: 18741

Offshore Structural Analysis Software Market

Published:
Report ID: 7488

PC Processor Market

Published:
Report ID: 8951

Cleaning Validation Software for Pharma Market

Published:
Report ID: 3542

Test And Burn-in Sockets Market

Published:
Report ID: 11111

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


support

24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN